Abstract
The ex vivo contraction response of the rat tracheal smooth muscle was examined after 10 min in vivo inhalation of soman and/or pretreatment with pyridostigmine and/or post-exposure treatment with HI-6 ([[[(4-aminocarbonyl) pyridinio]methoxy]methyl]-2[(hydroxyimino) methyl]pyridinium dichloride) or Toxogonin® (1,1′-[oxybis-(methylene)]bis[4-[(hydroxyimino)methyl]-pyridinium] dichloride). In vivo pretreatment with pyridostigmine was achieved by subcutaneous (s. c.) implantation of an osmotic pump that delivered pyridostigmine continuously (0.01 mg/h) in the neck region of the rat 18 h before soman exposure. The ex vivo cholinergic tracheal smooth muscle response increased during the first 60 min after soman exposure in animals pretreated with pyridostigmine. The amplitude of the contraction response in pyridostigmine pretreated animals was about 60% of control, compared to 15% of control without pyridostigmine pretreatment. Pyridostigmine pretreatment also produced significant recovery of the total cholinesterase (ChE) activity in plasma, but not in trachea and lung. Intraperitoneal (i. p.) injection of HI-6 or Toxogonin® (50 mg/kg), immediately after 10 min inhalation exposure to soman, also significantly improved the ex vivo cholinergic contraction response of the trachea (decapitation 15 min after oxime administration). The recovery of the physiological response with Toxogonin® was, however, not stable. HI-6 was superior to Toxogonin® with respect to the initial airway contraction response, and the response increased up to a stable level not significantly different from control. There was no significant reactivation of the ChE activity after treatment with the oximes. Combination of pyridostigmine pretreatment and oxime treatment enhanced the recovery of the tracheal contraction response and the ChE activity in the trachea compared to treatment with oximes alone. Experiments with in vitro exposure to soman followed by washout and addition of oximes were also performed. The results show that both oximes effectively re-establish the tracheal response when administered 10 min, but not 30 min, after soman. The effect of Toxogonin® was, however, contrary to the effect of HI-6, not stable. These results correspond to the in vivo exposure experiments. The results from this study indicate that HI-6 produces a more potent and stable recovery of an ex vivo peripheral cholinergic response than Toxogonin® after 10 min inhalation exposure to soman.
Similar content being viewed by others
References
Aas P, Sterri SH, Hjermstad HP, Fonnum F (1985) A method for generating toxic vapors of soman: toxicity of soman by inhalation in rats. Toxicol Appl Pharmacol 80: 437–445
Aas P, Veiteberg T, Fonnum F (1987) Acute and sub-acute inhalation of an organophosphate induce alteration of cholinergic muscarinic receptors. Biochem Pharmacol 36: 1261–1266
Adler M, Filbert MG (1990) Role of butyrylcholinesterase in canine tracheal smooth muscle function. FEBS Lett 267: 107–110
Barstad JAB, Lilleheil G, Skobba TJ (1969) Phosphorylated oximes. Arch Int Pharmacodyn Ther 179: 352–363
Berry WK, Davies DR (1966) Factors influencing the rate of “aging” of a series of alkylmethylphosphonyl-acetylcholinesterase. Biochem J 100: 572–576
Berry WK, Davies DR (1970) The use of carbamates and atropine in the protection of animals against poisoning by 1,2,2-trimethylpropyl methylphosphonofluoridate. Biochem Pharmacol 19: 927–934
Boskovic B, Kovacevic V, Jovanovic D (1984) PAM-2 Cl, HI-6 and HGG-12 in soman and tabun poisoning. Fundam Appl Toxicol 4: S106-S115
Burgen ASV, Hobbiger F (1951) The inhibition of cholinesterases by alkylphosphates and alkylphenolphosphates. Br J Pharmacol 6: 593–605
De Jong LPA, Ceulen DI (1978) Anticholinesterase activity and rate of decomposition of some phosphorylated oximes. Biochem Pharmacol 27: 857–863
Dirnhuber P, French MC, Green DM, Leadbeater L, Stratton JA (1979) The protection of primates against soman poisoning by pretreatment with pyridostigmine. J Pharm Pharmacol 31: 295–299
Farmer JB, Coleman JA (1970) A new preparation of the isolated intact trachea of the guinea-pig. J Pharm Pharmacol 22: 48–50
Fleisher JH, Harris LW (1965) Dealkylation as a mechanism for aging of cholinesterase after poisoning with pinacolyl methylphosphonofluoridate. Biochem Pharmacol 14: 641–650
Fleisher JH, Harris LW, Murtha EF (1967) Reactivation of pyridinium aldoxime methochloride (PAM) of inhibited cholinesterase activity in dogs after poisoning with pinacolyl methylphosphonofluoridate (Soman). J Pharmacol Exp Ther 156: 345–351
Fonnum F (1975) Phosphorylated oximes — a problem in therapy. In: Waser PG (ed) Cholinergic mechanisms. Raven Press, New York, pp 401–403
Gordon JJ, Leadbeater L, Maidment MP (1978) The protection of animals against organo-phosphate poisoning by pretreatment with a carbamate. Toxicol Appl Pharmacol 43: 207–216
Hackley BE Jr, Steinberg GM, Lamb JC (1959) Formation of potent inhibitors of AChE by reaction of pyridinaloximes with isopropyl methylphosphonofluoridate. Arch Biochem Biophys 80: 211–214
Hamilton MG, Lundy PM (1989) HI-6 therapy of soman and tabun poisoning in primates and rodents. Arch Toxicol 63: 144–149
Harris LW, Fleisher JH, Innerebner TA, Cliff WJ, Sim VM (1969) The effects of atropine-oxime therapy on cholinesterase activity and the survival of animals poisoned with O,O-diethyl-O-(2-isopropyl-6-methyl-4-pyrimidinyl) phosphorothioate. Toxicol Appl Pharmacol 15: 216–224
Harris LW, Talbot BG, Anderson DR, Lennox WJ, Green MD (1987) Oxime-induced decarbamylation and atropine/oxime therapy of guinea pigs intoxicated with pyridostigmine. Life Sci 40: 577–583
Koelle GB (1946) Protection of cholinesterase against irreversible inactivation by DFP in vitro. J Pharmacol Exp Ther 88: 232–237
Koster R (1946) Synergism and antagonisms between physostigmine and di-isopropyl fluorophosphate in cats. J Pharmacol Exp Ther 88: 39–46
Leadbeater L, Inns RH, Rylands JM (1985) Treatment of poisoning by soman. Fund Appl Toxicol 5: S225-S231
Lennox WJ, Harris LW, Talbot BG, Anderson DR (1985) Relationship between reversible acetylcholinesterase inhibition and efficacy against soman lethality. Life Sci 37: 793–798
Lim DK, Ito Y, Stewart T, Hoskins B, Ho IK (1988) Toxicity study of continuous administration of physostigmine salicylate. Pharmacol Biochem Behav 31: 627–631
Lipp JA, Dola T (1980) Comparison of the efficacy of HS-6 versus HI-6 when combined with atropine, pyridostigmine and clonazepam for soman poisoning in the monkey. Arch Int Pharmacodyn Ther 246: 138–148
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275
Lund Karlsen R, Fonnum F (1977) Properties of the external acetylcholinesterase in guinea-pig iris. J Neurochem 29: 151–156
McIsaac RJ, Koelle GB (1959) Comparison of the effects of inhibition external, internal and total acetylcholinesterase upon ganglionic transmission. J Pharmacol Exp Ther 126: 9–20
Miledi R, Molenaar PC, Polak RL (1984) Acetylcholinesterase activity in intact and homogenized skeletal muscle of the frog. J Physiol 349: 663–686
Mittag TW, Ehrenpreis S, Hehir RM (1971) Functional acetylcholinesterase of rat diaphragm muscle. Biochem Pharmacol 20: 2263–2273
Rogne O (1967) The reaction of acetylcholinesterase with phosphorylated oximes. Biochem Pharmacol 16: 1853–1858
Schoene K (1972) Reaktiviering von O,O-diathylphosphorylacetylcholinesterase. Biochem Pharmacol 21: 163–170
Shih T-M, Whalley CE, Valdes JJ (1991) A comparison of cholinergic effects of HI-6 and pralidoxime-2-chloride (2-PAM) in soman poisoning. Toxicol Lett 55: 131–147
Sterri SH, Fonnum F (1978) Isolation of organic anions by extraction with liquid anion exchangers and its application to micromethods for acetylcholinesterase and 4-aminobutyrate aminotransferase. Eur J Biochem 91: 215–222
Sterri SH, Rognerud B, Fiskum SE, Lyngaas S (1979) Effect of toxogonin and PS2 on the toxicity of carbamates and organophosphorus compounds. Acta Pharmacol Toxicol 45: 9–15
Sterri SH, Lyngaas S, Fonnum F (1981) Toxicity of soman after repetitive injection of sublethal doses in guinea-pig and mouse. Acta Pharmacol Toxicol 49: 8–13
Sterri SH, Lyngaas S, Fonnum F (1983) Cholinesterase and carboxylesterase activities in soman poisoned rats treated with bis-pyridinium mono-oximes HI-6 and HS-6. Biochem Pharmacol 32: 1646–1649
Van Helden HPM, Van der Wiel HJ, Wolthuis OL (1986) Prophylactic and therapeutic efficacy of the soman-simulator, pinacolyl dimethylphosphinate. J Pharm Pharmacol 38: 439–445
Van Helden HPM, De Lange J, Busker RW, Melchers BPC (1991) Therapy of organo-phosphate poisoning in the rat by direct effects of oximes unrelated of ChE reactivation. Arch Toxicol 65: 586–593
Walday P, Aas P, Fonnum F (1991) Inhibition of serine esterases in different rat tissues following inhalation of soman. Biochem Pharmacol 41: 151–153
Walters EH, O'Byrne PM, Fabbri LM, Graf PD, Holtzman MJ, Nagel JA (1984) Control of neurotransmission by prostaglandins in canine trachealis smooth muscle. J Appl Physiol 57: 129–134
Wilson IB, Ginsburg S (1955) A powerful reactivator of alkylphosphateinhibited acetylcholinesterase. Biochim Biophys Acta 18: 168–170
Wolthuis OL, Kepner LA (1978) Successful oxime therapy one hour after soman intoxication in the rat. Eur J Pharmacol 49: 415–425
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Walday, P., Aas, P., Haider, T. et al. Effect of pyridostigmine pretreatment, HI-6 and toxogonin (®) treatment on rat tracheal smooth muscle response to cholinergic stimulation after organophosphorus inhalation exposure. Arch Toxicol 67, 212–219 (1993). https://doi.org/10.1007/BF01973310
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01973310